IGF1 and osteoporosis: Microenvironmental agents for the improvement of MSC function in osteoporosis have also been reported to include the gasotransmitter H2S donor GYY4317 and Insulin-like growth factor 1 (IGF1), together with its binding protein (IGFBP3).